Connect with us

Health

Research into COVID treatments catching up – Esperance Express

Australia has closed a deal for 300,000 courses of an antiviral pill showing promising signs of slashing COVID-19 deaths and…

Published

on

Article feature image

Australia has closed a deal for 300,000 courses of an antiviral pill showing promising signs of slashing COVID-19 deaths and hospitalisations.
Molnupiravir is still being trialled in the US and is yet to gain regulatory authorisation.
But the federal government…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending